Physician

Adriana Lisinschi, M.D.

According to 2025 Medicare claims, Adriana Lisinschi, M.D. (NPI: 1013331735) practices hematology/oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12065-4154.

Lisinschi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 686 traditional Medicare patients, billed 120,319 HCPCS/CPT codes, and received $1,476,125 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,423 prescription claims across 279 beneficiaries totaling $1,475,357 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 30 claims. Open Payments data shows 2 records totaling $135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $180,836 and ending at $1,476,125. Concurrently, Part D prescription costs have risen steadily, from $26,377 to $1,475,357. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	173	20,626	$180,836
2016	767	104,860	$1,151,426
2017	517	91,063	$1,242,954
2018	562	99,547	$1,595,751
2019	574	135,770	$1,568,560
2020	586	131,285	$1,972,160
2021	614	132,606	$1,466,754
2022	679	142,324	$1,669,042
2023	655	116,312	$1,174,264
2024	686	120,319	$1,476,125

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	88	$26,377
2016	160	608	$245,196
2017	183	892	$534,607
2018	177	1,035	$421,075
2019	174	1,131	$872,452
2020	187	1,201	$991,907
2021	187	1,155	$1,321,285
2022	209	1,113	$1,321,413
2023	224	1,184	$1,062,044
2024	279	1,423	$1,475,357

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	13	$529
2016	N/R	14	$349
2017	N/R	N/R	N/R
2018	N/R	12	$3,305
2019	N/R	14	$3,222
2020	N/R	13	$1,703
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	30	$7,890
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	194	264	$59
80053	Blood test, comprehensive group of blood chemicals	444	867	$10
36415	Insertion of needle into vein for collection of blood sample	480	968	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	473	957	$8
83615	Lactate dehydrogenase (enzyme) level	193	366	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	26	728	$403,889
Lenalidomide	Lenalidomide	22	504	$199,365
Imbruvica	Ibrutinib	12	336	$196,347
Ninlaro	Ixazomib Citrate	12	336	$158,798
Lonsurf	Trifluridine/Tipiracil Hcl	12	336	$98,841

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$135	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adriana Lisinschi, M.D.?

Tedicare shows public-source Medicare data for Adriana Lisinschi, M.D. (NPI 1013331735), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana Lisinschi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adriana Lisinschi, M.D.?

Adriana Lisinschi, M.D. is linked to NEW YORK ONCOLOGY HEMATOLOGY, P.C. (billing NPI 1609863448) in the available physician profile data.

Does Adriana Lisinschi, M.D. have Open Payments data?

Adriana Lisinschi, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.